ID B4DHT6_HUMAN Unreviewed; 341 AA. AC B4DHT6; DT 23-SEP-2008, integrated into UniProtKB/TrEMBL. DT 23-SEP-2008, sequence version 1. DT 02-SEP-2026, entry version 77. DE RecName: Full=Glucosylceramidase {ECO:0000256|RuleBase:RU361188}; DE EC=3.2.1.45 {ECO:0000256|RuleBase:RU361188}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58248.1}; RN [1] {ECO:0000313|EMBL:BAG58248.1} RP NUCLEOTIDE SEQUENCE. RC TISSUE=Caudate nucleus {ECO:0000313|EMBL:BAG58248.1}; RA Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A., RA Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y., RA Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T., RA Sugano S., Nomura N., Isogai T.; RT "NEDO human cDNA sequencing project focused on splicing variants."; RL Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases. CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(beta-D-galactosyl)-N-dodecanoylsphing-4-enine + cholesterol CC = cholesteryl 3-beta-D-galactoside + N-dodecanoylsphing-4-enine; CC Xref=Rhea:RHEA:70255, ChEBI:CHEBI:16113, ChEBI:CHEBI:72956, CC ChEBI:CHEBI:73432, ChEBI:CHEBI:189066; CC Evidence={ECO:0000256|ARBA:ARBA00033703}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70256; CC Evidence={ECO:0000256|ARBA:ARBA00033703}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70257; CC Evidence={ECO:0000256|ARBA:ARBA00033703}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine + H2O = D- CC galactose + an N-acylsphing-4-enine; Xref=Rhea:RHEA:14297, CC ChEBI:CHEBI:4139, ChEBI:CHEBI:15377, ChEBI:CHEBI:18390, CC ChEBI:CHEBI:52639; EC=3.2.1.46; CC Evidence={ECO:0000256|ARBA:ARBA00047842}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14298; CC Evidence={ECO:0000256|ARBA:ARBA00047842}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine + CC cholesterol = cholesteryl 3-beta-D-galactoside + an N-acylsphing-4- CC enine; Xref=Rhea:RHEA:70235, ChEBI:CHEBI:16113, ChEBI:CHEBI:18390, CC ChEBI:CHEBI:52639, ChEBI:CHEBI:189066; CC Evidence={ECO:0000256|ARBA:ARBA00048182}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70236; CC Evidence={ECO:0000256|ARBA:ARBA00048182}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70237; CC Evidence={ECO:0000256|ARBA:ARBA00048182}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine + H2O = an N- CC acylsphing-4-enine + D-glucose; Xref=Rhea:RHEA:13269, CC ChEBI:CHEBI:4167, ChEBI:CHEBI:15377, ChEBI:CHEBI:22801, CC ChEBI:CHEBI:52639; EC=3.2.1.45; CC Evidence={ECO:0000256|ARBA:ARBA00001013}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13270; CC Evidence={ECO:0000256|ARBA:ARBA00001013}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine + cholesterol CC = cholesteryl 3-beta-D-glucoside + an N-acylsphing-4-enine; CC Xref=Rhea:RHEA:58264, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:22801, ChEBI:CHEBI:52639; CC Evidence={ECO:0000256|ARBA:ARBA00048055}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58265; CC Evidence={ECO:0000256|ARBA:ARBA00048055}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:58266; CC Evidence={ECO:0000256|ARBA:ARBA00048055}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-xylosyl-(1<->1')-N-acylsphing-4-enine + cholesterol = CC cholesteryl 3-beta-D-xyloside + an N-acylsphing-4-enine; CC Xref=Rhea:RHEA:70239, ChEBI:CHEBI:16113, ChEBI:CHEBI:52639, CC ChEBI:CHEBI:189067, ChEBI:CHEBI:189068; CC Evidence={ECO:0000256|ARBA:ARBA00048817}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70240; CC Evidence={ECO:0000256|ARBA:ARBA00048817}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-(1<->1')-N-(15Z-tetracosenoyl)-sphing-4-enine CC + cholesterol = N-(15Z-tetracosenoyl)-sphing-4-enine + cholesteryl 3- CC beta-D-glucoside; Xref=Rhea:RHEA:70315, ChEBI:CHEBI:16113, CC ChEBI:CHEBI:17495, ChEBI:CHEBI:74450, ChEBI:CHEBI:76302; CC Evidence={ECO:0000256|ARBA:ARBA00048880}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70316; CC Evidence={ECO:0000256|ARBA:ARBA00048880}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70317; CC Evidence={ECO:0000256|ARBA:ARBA00048880}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-(1<->1)-N-octadecanoylsphing-4-enine + CC cholesterol = cholesteryl 3-beta-D-glucoside + N-octadecanoylsphing- CC 4-enine; Xref=Rhea:RHEA:70311, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:72961, ChEBI:CHEBI:84719; CC Evidence={ECO:0000256|ARBA:ARBA00033636}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70312; CC Evidence={ECO:0000256|ARBA:ARBA00033636}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70313; CC Evidence={ECO:0000256|ARBA:ARBA00033636}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-N-(9Z-octadecenoyl)-sphing-4E-enine + CC cholesterol = N-(9Z-octadecenoyl)-sphing-4-enine + cholesteryl 3- CC beta-D-glucoside; Xref=Rhea:RHEA:58324, ChEBI:CHEBI:16113, CC ChEBI:CHEBI:17495, ChEBI:CHEBI:77996, ChEBI:CHEBI:139140; CC Evidence={ECO:0000256|ARBA:ARBA00049516}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58325; CC Evidence={ECO:0000256|ARBA:ARBA00049516}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:58326; CC Evidence={ECO:0000256|ARBA:ARBA00049516}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-N-dodecanoylsphing-4-enine + cholesterol = N- CC dodecanoylsphing-4-enine + cholesteryl 3-beta-D-glucoside; CC Xref=Rhea:RHEA:70307, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:72956, ChEBI:CHEBI:76297; CC Evidence={ECO:0000256|ARBA:ARBA00048698}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70308; CC Evidence={ECO:0000256|ARBA:ARBA00048698}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70309; CC Evidence={ECO:0000256|ARBA:ARBA00048698}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-N-octanoylsphing-4E-enine + cholesterol = N- CC octanoylsphing-4-enine + cholesteryl 3-beta-D-glucoside; CC Xref=Rhea:RHEA:70303, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:45815, ChEBI:CHEBI:65222; CC Evidence={ECO:0000256|ARBA:ARBA00049379}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70304; CC Evidence={ECO:0000256|ARBA:ARBA00049379}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70305; CC Evidence={ECO:0000256|ARBA:ARBA00049379}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-xylosyl-(1<->1')-N-(9Z-octadecenoyl)-sphing-4-enine + CC cholesterol = cholesteryl 3-beta-D-xyloside + N-(9Z-octadecenoyl)- CC sphing-4-enine; Xref=Rhea:RHEA:70251, ChEBI:CHEBI:16113, CC ChEBI:CHEBI:77996, ChEBI:CHEBI:189067, ChEBI:CHEBI:189081; CC Evidence={ECO:0000256|ARBA:ARBA00033633}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70252; CC Evidence={ECO:0000256|ARBA:ARBA00033633}; CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesteryl 3-beta-D-glucoside + H2O = cholesterol + D- CC glucose; Xref=Rhea:RHEA:11956, ChEBI:CHEBI:4167, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:17495; CC Evidence={ECO:0000256|ARBA:ARBA00033646}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11957; CC Evidence={ECO:0000256|ARBA:ARBA00033646}; CC -!- PATHWAY: Lipid metabolism. {ECO:0000256|ARBA:ARBA00005189}. CC -!- PATHWAY: Sphingolipid metabolism. {ECO:0000256|ARBA:ARBA00004991}. CC -!- PATHWAY: Steroid metabolism; cholesterol metabolism. CC {ECO:0000256|ARBA:ARBA00004731}. CC -!- SUBCELLULAR LOCATION: Lysosome membrane CC {ECO:0000256|ARBA:ARBA00004207}; Peripheral membrane protein CC {ECO:0000256|ARBA:ARBA00004207}; Lumenal side CC {ECO:0000256|ARBA:ARBA00004207}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 30 family. CC {ECO:0000256|ARBA:ARBA00005382, ECO:0000256|RuleBase:RU361188}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK295259; BAG58248.1; -; mRNA. DR AlphaFoldDB; B4DHT6; -. DR Allergome; 8244; Hom s Glucocerebrosidase. DR CAZy; GH30; Glycoside Hydrolase Family 30. DR PeptideAtlas; B4DHT6; -. DR PhylomeDB; B4DHT6; -. DR UniPathway; UPA00296; -. DR GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell. DR GO; GO:0004336; F:galactosylceramidase activity; IEA:UniProtKB-EC. DR GO; GO:0004348; F:glucosylceramidase activity; IEA:UniProtKB-EC. DR GO; GO:0046527; F:glucosyltransferase activity; IEA:UniProtKB-ARBA. DR GO; GO:0005102; F:signaling receptor binding; IEA:UniProtKB-ARBA. DR GO; GO:0050295; F:steryl-beta-glucosidase activity; IEA:RHEA. DR GO; GO:0006914; P:autophagy; IEA:UniProtKB-ARBA. DR GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0006680; P:glucosylceramide catabolic process; IEA:UniProtKB-ARBA. DR GO; GO:0009247; P:glycolipid biosynthetic process; IEA:UniProtKB-ARBA. DR GO; GO:0007040; P:lysosome organization; IEA:UniProtKB-ARBA. DR GO; GO:0030163; P:protein catabolic process; IEA:UniProtKB-ARBA. DR GO; GO:0016241; P:regulation of macroautophagy; IEA:UniProtKB-ARBA. DR GO; GO:0042391; P:regulation of membrane potential; IEA:UniProtKB-ARBA. DR GO; GO:0042176; P:regulation of protein catabolic process; IEA:UniProtKB-ARBA. DR GO; GO:0032006; P:regulation of TOR signaling; IEA:UniProtKB-ARBA. DR FunFam; 3.20.20.80:FF:000030; Lysosomal acid glucosylceramidase; 1. DR Gene3D; 3.20.20.80; Glycosidases; 1. DR InterPro; IPR017853; GH_hydrolase_sf. DR InterPro; IPR001139; Glyco_hydro_30. DR InterPro; IPR033453; Glyco_hydro_30_TIM-barrel. DR PANTHER; PTHR11069; GLUCOSYLCERAMIDASE; 1. DR PANTHER; PTHR11069:SF34; GLUCOSYLCERAMIDASE; 1. DR Pfam; PF02055; Glyco_hydro_30; 1. DR PRINTS; PR00843; GLHYDRLASE30. DR SUPFAM; SSF51445; (Trans)glycosidases; 1. PE 2: Evidence at transcript level; KW Cholesterol metabolism {ECO:0000256|ARBA:ARBA00022548}; KW Glycosidase {ECO:0000256|ARBA:ARBA00023295, ECO:0000256|RuleBase:RU361188}; KW Glycosyltransferase {ECO:0000256|ARBA:ARBA00022676}; KW Hydrolase {ECO:0000256|ARBA:ARBA00022801, ECO:0000256|RuleBase:RU361188}; KW Lipid metabolism {ECO:0000256|ARBA:ARBA00023098, KW ECO:0000256|RuleBase:RU361188}; KW Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP}; KW Sphingolipid metabolism {ECO:0000256|ARBA:ARBA00022919, KW ECO:0000256|RuleBase:RU361188}; KW Steroid metabolism {ECO:0000256|ARBA:ARBA00023221}; KW Sterol metabolism {ECO:0000256|ARBA:ARBA00023166}; KW Transferase {ECO:0000256|ARBA:ARBA00022679}. FT SIGNAL 1..37 FT /evidence="ECO:0000256|SAM:SignalP" FT CHAIN 38..341 FT /note="Glucosylceramidase" FT /evidence="ECO:0000256|SAM:SignalP" FT /id="PRO_5002800808" FT DOMAIN 65..338 FT /note="Glycosyl hydrolase family 30 TIM-barrel" FT /evidence="ECO:0000259|Pfam:PF02055" SQ SEQUENCE 341 AA; 38476 MW; EB9B41EAABC5141A CRC64; MEFSSPSREE CPKPSGRVSI MAGSLTGLLL LQAVSWASDE CLQPLQEQKQ WALDGAEYRT IQANCTGTGI GYNIIWVPMA SCDFSIRTYT YADTPDDFQL HNFSLPEEDT KLKIPLIHRA LQLAQRPVSL LASPWTSPTR LKTKGAGNGK GPLKGQPRDI YHQTWARYIV KFLDAYAEHK LQFWAVTAEN EPSAGLLSGY PFQCLGFTPE HQRDFIARDL GPTLANGTHH NVRLLMLDDQ RLLLPHWAKV VLTDPEAAKY VHGIAVHWYL DFLAPAKATL RETHHLFPNT MLFASEACVG SKFWEQSVRL GSWDRGMQYS HSIITNLLYH VVGWTDWNPS L //